📰 Flurotech Ltd News
Page 2 - Flurotech Ltd News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Flurotech Ltd. Real-time updates on events, politics, business and more.
June 10, 2021
/PRNewswire/ - FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary FluroTest Diagnostic Systems ("FluroTest" or The Company), a diagnostics...
May 13, 2021
/PRNewswire/ - FluroTech LTD. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary FluroTest Diagnostics Systems ("FluroTest" or The Company), a diagnostics...
May 10, 2021
CALGARY, AB, May 10, 2021 /PRNewswire/ - FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) and wholly owned subsidiary "FluroTest" or The Company), a diagnostics technology leader in high output rapid antigen testing for the detection of SARS-CoV-2 and other pathogens, today announces the next phase of its ongoing clinical trials with its trial partner Toolbox Medical Innovations ("Toolbox"). The Company is pleased to report that approximately 600 volunteer participants, including both symptomati...
May 4, 2021
"FluroTest" or The Company), a first-mover in surge-scale rapid antigen testing for the detection of SARS-CoV-2 and other pathogens, are pleased to announce based on the data collected to date that the FluroTest platform will be capable of detecting the primary variants of concern now spreading across North America and fueling serious outbreaks around the world. Many of the variants of concern are mutations that alter the viral structure through the spike ("S") protein found on the molecular su...
May 3, 2021
"FluroTest" or The Company), a first-mover in surge-scale rapid antigen testing for the detection of SARS-CoV-2 and other pathogens, today announces it has signed a strategic Memorandum of Understanding ("MOU") with TTS"), one of North Americas premier providers of health testing to the professional sports, entertainment, venue ticketing and travel industries. Under the terms of the non-binding MOU, FluroTest and TTS will launch and pilot a first-of-its-kind, high-volume Covid-19 testing sy...
April 13, 2021
FluroTech” or the “ Company“), a leading developer of spectroscopy-based technology, is pleased to announce it has received conditional approval from the TSX Venture Exchange (the “ Exchange“) to commence an Early Warrant Exercise Incentive Program (“ EWEIP“) intended to encourage the early exercise of up to 18,550,000 Warrants (as defined and described below). In January of 2021, FluroTech closed, in two tranches, a non-brokered private placement of units (“ Units“), for aggr...
April 6, 2021
Cautionary Statement Regarding Forward-Looking Information This news release contains “forward-looking information” within the meaning of Canadian securities legislation. Forward-looking information generally refers to information about an issuer’s business, capital, technology or operations that is prospective in nature, and includes future-oriented financial information about the issuer’s perspective financial performance or financial position. The forward-looking information in this ...
March 4, 2021
CALGARY, Alberta, March 04, 2021 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, together with joint venture FluroTest, LLC (“FluroTest”), a first-mover in surge-scale rapid antigen testing for the detection of SARS-CoV-2 and other pathogens, are pleased to announce that an agreement with Toolbox Medical Innovations (“Toolbox”) has been sign...
February 19, 2021
CALGARY, Alberta, Feb. 19, 2021 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF) (“FluroTech” or the “Company”), a leading developer of spectroscopy-based technology, together with joint venture FluroTest, LLC (“FluroTest”), a first-mover in surge-scale rapid antigen testing for the detection of SARS-CoV-2 and other pathogens, today announced that pre-production development of three functioning pandemic defense platform systems are now unde...
January 28, 2021
TSXV: OTCQB: FLURF) (“FluroTech” or the “Company”), is pleased to announce that is has engaged Venture Liquidity Providers Inc. (“VLP”), subject to regulatory approval, to provide market-making services for the purpose of maintaining an orderly trading market and improving the liquidity of the Company’s shares. The market-making service will be undertaken by VLP through a registered broker, W.D. Latimer Co. Ltd., in compliance with the applicable policies of the TSX Venture Exch...